Anca Milea

发表

CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma

P. Shaw, B. Slomovitz, A. Milea, 2019, EBioMedicine.

C/EBPδ demonstrates a dichotomous role in tumor initiation and promotion of epithelial carcinoma

P. Shaw, B. Slomovitz, A. Milea, 2019, bioRxiv.

A distinct innate lymphoid cell population regulates tumor-associated T cells

Trevor J Pugh, T. Pugh, B. Clarke, 2017, Nature Medicine.

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.

Carl Virtanen, Barry Rosen, B. Rosen, 2010, Gynecologic oncology.

Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla—Site of Origin of Serous Carcinoma of the Ovary

L. Cope, P. Shaw, M. Schlumbrecht, 2020, Cancers.

Hormone Receptor Expression and Disease Prognosis in High-Grade Serous Ovarian Cancer

P. Shaw, M. Schlumbrecht, George, 2023, medRxiv.

Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma

B. Gallie, H. Berman, P. Shaw, 2014, Modern Pathology.

Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status

P. Shaw, A. Milea, S. George, 2012, Clinical Cancer Research.

Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers

P. Shaw, C. Virtanen, Monika Sharma, 2011, The Journal of pathology.

Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis

P. Shaw, A. Tone, A. Milea, 2016, Oncogene.

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

I. Flinn, K. Savage, M. Minden, 2021, Clinical Cancer Research.

C/EBPδ demonstrates a dichotomous role in tumor initiation and promotion of epithelial carcinoma

P. Shaw, B. Slomovitz, A. Milea, 2019, bioRxiv.